17 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
investment power with respect to all shares that they beneficially own, subject to applicable community property laws.
Applicable percentage ownership … indicated in the footnotes to this table and subject to community property laws where applicable, the Company believes that each of the stockholders
8-K
EX-99.1
0ucm90j9i gc
14 Nov 22
Acumen Pharmaceuticals Reports Third Quarter 2022
4:10pm
DEF 14A
wv0lc4ww4ckek5g8
27 Apr 22
Definitive proxy
5:03pm
10-K
sl2wa
28 Mar 22
Annual report
4:51pm
10-Q
plq80v9auxshp
16 Aug 21
Quarterly report
4:51pm
424B4
pu37q1b1n vl4uq
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
awot4e 4w6hdsu25e
24 Jun 21
IPO registration (amended)
8:17am
S-1
EX-4.1
m1gnal4dqjk0 6rzwyq
9 Jun 21
IPO registration
5:02pm
S-1
i0nv r7mo9spzpspt
9 Jun 21
IPO registration
5:02pm
DRS/A
EX-4.1
j32myla3hozl2d1g
14 May 21
Draft registration statement (amended)
12:00am
DRS/A
957al
14 May 21
Draft registration statement (amended)
12:00am
DRS
153ujz
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next